KPTI·48576U205·US·equity·Healthcare - Biotechnology-13D/G
KPTI (KARYOPHARM THERAPEUTICS INC) is held by 40 institutional investors as of Q4 2025. Net institutional sentiment: Bullish.
See how KPTI's score breaks down across 4 SEC sources
This is taking longer than usual. Please try again in a moment.
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer